These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25251334)

  • 1. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term delivery of protein and peptide therapeutics for cancer therapies.
    Sikder S; Gote V; Alshamrani M; Sicotte J; Pal D
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1113-1131. PubMed ID: 31498012
    [No Abstract]   [Full Text] [Related]  

  • 3. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated in vitro release testing method for a long-acting peptide-PLGA formulation.
    Goel M; Leung D; Famili A; Chang D; Nayak P; Al-Sayah M
    Eur J Pharm Biopharm; 2021 Aug; 165():185-192. PubMed ID: 33992753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and peptide parenteral controlled delivery.
    Pawar R; Ben-Ari A; Domb AJ
    Expert Opin Biol Ther; 2004 Aug; 4(8):1203-12. PubMed ID: 15268656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.
    Teekamp N; Duque LF; Frijlink HW; Hinrichs WL; Olinga P
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1311-31. PubMed ID: 25601515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases.
    Patel SP; Vaishya R; Patel A; Agrahari V; Pal D; Mitra AK
    J Microencapsul; 2016; 33(2):103-13. PubMed ID: 26964498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microspheres and microcapsules for protein delivery: strategies of drug activity retention.
    Wang L; Liu Y; Zhang W; Chen X; Yang T; Ma G
    Curr Pharm Des; 2013; 19(35):6340-52. PubMed ID: 23470006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in protein and peptide parenteral delivery approaches.
    Patel A; Cholkar K; Mitra AK
    Ther Deliv; 2014 Mar; 5(3):337-65. PubMed ID: 24592957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Polymeric Drug Carriers for Local Delivery: The Case of
    Okur NÜ; Yağcılar AP; Siafaka PI
    Curr Drug Deliv; 2020; 17(8):675-693. PubMed ID: 32510291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable implants for the sustained release of protein and peptide drugs.
    Agarwal P; Rupenthal ID
    Drug Discov Today; 2013 Apr; 18(7-8):337-49. PubMed ID: 23410799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles.
    Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A
    Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
    Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
    Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics.
    Pagels RF; Prud'homme RK
    J Control Release; 2015 Dec; 219():519-535. PubMed ID: 26359125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.
    Bale S; Khurana A; Reddy AS; Singh M; Godugu C
    Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically established biodegradable long acting injectables: An industry perspective.
    Nkanga CI; Fisch A; Rad-Malekshahi M; Romic MD; Kittel B; Ullrich T; Wang J; Krause RWM; Adler S; Lammers T; Hennink WE; Ramazani F
    Adv Drug Deliv Rev; 2020 Dec; 167():19-46. PubMed ID: 33202261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.
    Pai SS; Tilton RD; Przybycien TM
    AAPS J; 2009 Mar; 11(1):88-98. PubMed ID: 19199044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.